Recreational Drug Use: Clinical Trials

7 trials for Recreational Drug Use, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 4 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Not applicable2Completed 2

Follow Recreational Drug Use: new trials by email Literature Review of Recreational Drug Use trials Research Report on Recreational Drug Use

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Teen Connection Project for Trans and Gender Minority Youth
Teen Connection Project (TCP) - Recreational Drug Use, Sexual Violence
Not applicableCompletedUniversity of Michigan562024-07-222026-05-22
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
PF614, Oxycodone Hydrochloride 40 mg, Placebo - Recreational Drug Use
Phase 1CompletedEnsysce Biosciences322022-10-052024-09-24
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
PF614, Oxycodone, Placebo - Recreational Drug Use
Phase 1CompletedEnsysce Biosciences272022-06-102024-09-24
Chemsex Engagement and HIV Biomedical Prevention in MSM
HIV test - Recreational Drug Use
CompletedChinese University of Hong Kong7332021-06-012025-01-23
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
Lasmiditan, Alprazolam, Placebo - Recreational Drug Use, Prescription Drug Abuse (Not Dependent)
Phase 1CompletedEli Lilly and Company962017-09-152020-01-10
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo
Placebo, EMBEDA - morphine sulfate/ naltrexone hydrochloride, morphine sulfate CR crushed. - Narcotic Abuse, Opioid-related Disorders
Phase 1CompletedPfizer332010-08-012012-06-08
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
3,4-methylenedioxymethamphetamine or Placebo - MDMA Discontinuation Syndrome
Not applicableCompletedCalifornia Pacific Medical Center Research Institute122010-04-012013-05-31

Narrower conditions

Substance-Related Disorders (2)  ·  Agnosia (1)  ·  Alcohol Drinking (1)  ·  Anxiety Disorders (1)  ·  Chronic Pain (1)  ·  Depression (1)  ·  Homosexuality (1)  ·  Narcotic-Related Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Risk-Taking (1)  ·  Sexual Behavior (1)  ·  Suicidal Ideation (1)

Broader conditions

Behavior (7)  ·  Mental Disorders (4)  ·  Chemically-Induced Disorders (3)  ·  Behavioral Symptoms (1)  ·  Drinking Behavior (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Perceptual Disorders (1)  ·  Self-Injurious Behavior (1)  ·  Sexual Behavior (1)  ·  Sexuality (1)  ·  Signs and Symptoms (1)

Interventions

Oxycodone (2)  ·  Tablets (2)  ·  Alprazolam (1)  ·  HIV Testing (1)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Naltrexone (1)  ·  lasmiditan (1)

Sponsors

Ensysce Biosciences (2)  ·  California Pacific Medical Center Research Institute (1)  ·  Chinese University of Hong Kong (1)  ·  Eli Lilly and Company (1)  ·  Pfizer (1)  ·  University of Michigan (1)

Countries

United States (5)  ·  Hong Kong (1)

Top investigators

Glen Apseloff, MD, FCP (1)  ·  John Mendelson, MD (1)  ·  Katie M Edwards, PhD (1)  ·  Lynn Kirkpatrick, PhD (1)

Results publications

PMID 23936895

NIH funding

R01DA016776 (1)